Porcari G, Collyer J, Adang L, Rajan D
Neurol Genet. 2025; 11(1):e200229.
PMID: 39810751
PMC: 11731373.
DOI: 10.1212/NXG.0000000000200229.
Signoria I, Zwartkruis M, Geerlofs L, Perenthaler E, Faller K, James R
Mol Ther Methods Clin Dev. 2024; 32(4):101379.
PMID: 39655308
PMC: 11626024.
DOI: 10.1016/j.omtm.2024.101379.
Maretina M, Koroleva V, Shchugareva L, Glotov A, Kiselev A
Biomedicines. 2024; 12(11).
PMID: 39595052
PMC: 11591959.
DOI: 10.3390/biomedicines12112486.
Stam M, Tan H, Schmidt R, van den Heuvel M, van den Berg L, Wadman R
Neuroimage Clin. 2024; 44:103708.
PMID: 39577334
PMC: 11617753.
DOI: 10.1016/j.nicl.2024.103708.
Coratti G, Bovis F, Pera M, Civitello M, Rohwer A, Salmin F
Eur J Neurol. 2024; 31(12):e16517.
PMID: 39392101
PMC: 11555017.
DOI: 10.1111/ene.16517.
Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1-3.
Ouyang S, Peng X, Huang W, Bai J, Wang H, Jin Y
Front Neurol. 2024; 15:1382410.
PMID: 39286802
PMC: 11404040.
DOI: 10.3389/fneur.2024.1382410.
A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA).
Marti Y, Ribero V, Batson S, Mitchell S, Gorni K, Gusset N
J Neuromuscul Dis. 2024; 11(5):889-904.
PMID: 38943396
PMC: 11380303.
DOI: 10.3233/JND-230248.
Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.
Kokaliaris C, Evans R, Hawkins N, Mahajan A, Scott D, Sutherland C
Adv Ther. 2024; 41(6):2414-2434.
PMID: 38705943
PMC: 11133132.
DOI: 10.1007/s12325-024-02845-6.
Real-world evidence: Risdiplam in a patient with spinal muscular atrophy type I with a novel splicing mutation and one SMN2 copy.
Ma K, Zhang K, Chen D, Wang C, Abdalla M, Zhang H
Hum Mol Genet. 2024; 33(13):1120-1130.
PMID: 38520738
PMC: 11190614.
DOI: 10.1093/hmg/ddae052.
Natural History of Mandibular Function in Spinal Muscular Atrophy Types 2 and 3.
van Bruggen H, Wijngaarde C, Asselman F, Stam M, Creugers N, Wadman R
J Neuromuscul Dis. 2024; 11(3):655-664.
PMID: 38517801
PMC: 11091609.
DOI: 10.3233/JND-240007.
Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey.
Curry M, Cruz R, Belter L, Schroth M, Jarecki J
Neurol Ther. 2024; 13(3):583-598.
PMID: 38430355
PMC: 11136895.
DOI: 10.1007/s40120-024-00587-9.
Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy.
Brown L, Hoffman K, Corbo-Galli C, Dong S, Zumpf K, Weigel C
J Clin Med. 2024; 13(4.
PMID: 38398235
PMC: 10889380.
DOI: 10.3390/jcm13040921.
Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI.
Otto L, Froeling M, van Eijk R, Wadman R, Cuppen I, van der Woude D
J Neuromuscul Dis. 2023; 11(1):91-101.
PMID: 38073395
PMC: 10789331.
DOI: 10.3233/JND-221671.
Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population.
Belter L, Peterson I, Jarecki J
Neurol Ther. 2023; 12(6):2161-2175.
PMID: 37856000
PMC: 10630176.
DOI: 10.1007/s40120-023-00552-y.
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.
Ribero V, Marti Y, Batson S, Mitchell S, Gorni K, Gusset N
Neurology. 2023; 101(21):e2103-e2113.
PMID: 37813581
PMC: 10663020.
DOI: 10.1212/WNL.0000000000207878.
Innovating spinal muscular atrophy models in the therapeutic era.
Signoria I, van der Pol W, Groen E
Dis Model Mech. 2023; 16(9).
PMID: 37787662
PMC: 10565113.
DOI: 10.1242/dmm.050352.
Feasibility and tolerability of multimodal peripheral electrophysiological techniques in a cohort of patients with spinal muscular atrophy.
Ros L, Sleutjes B, Stikvoort Garcia D, Goedee H, Asselman F, van den Berg L
Clin Neurophysiol Pract. 2023; 8:123-131.
PMID: 37554725
PMC: 10404501.
DOI: 10.1016/j.cnp.2023.06.001.
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.
Glascock J, Darras B, Crawford T, Sumner C, Kolb S, DiDonato C
J Neuromuscul Dis. 2023; 10(5):937-954.
PMID: 37458045
PMC: 10578234.
DOI: 10.3233/JND-230054.
The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial.
Kant-Smits K, Bartels B, Asselman F, Veldhoen E, van Eijk R, van der Pol W
BMC Neurol. 2023; 23(1):118.
PMID: 36959618
PMC: 10035150.
DOI: 10.1186/s12883-023-03136-3.
Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study.
Veldhoen E, Wijngaarde C, van Eijk R, Asselman F, Seddiqi N, Otto L
Orphanet J Rare Dis. 2023; 18(1):40.
PMID: 36823666
PMC: 9951433.
DOI: 10.1186/s13023-023-02634-4.
